News

Vitamins got their name in the early 1900s when London-based Polish biochemist Casimir Funk—one of many scientists seeking ...
BUFFALO, NEW YORK / ACCESS Newswire / June 23, 2025 / ZeptoMetrix® is pleased to announce the launch of NATtrol™ Influenza A ...
Phylogeny of HA genes and the infectivity in organotypic-differentiated primary normal human bronchial epithelial (NHBE) cells, and horizontal transmission between ferrets of H9N2 AIVs.
Potentially risky DNA sequences, such as pathogen genes that contribute to virulence, might be necessary for studying disease and designing vaccines, for example. Customer screening, not just sequence ...
However, there are various types of virus receptors. The HA of avian influenza viruses binds to “avian-type” receptors containing α2-3 sialic acid.
The evolution of viral antigens like HA can result in a virus becoming more virulent or able to jump species more easily. There are fears that H5N1 bird flu may mutate to be able to be spread from ...
Molecular analysis was done to determine influenza type and subtype, and then segments encoding the HA gene of Influenza B viruses were performed. Results: Of 8497 samples collected and tested, 639 (7 ...
The Centers for Disease Control and Prevention said Thursday that a single severe case of bird flu detected in a Louisiana man shows a rare mutation of the virus. The patient’s samples showed ...
The CDC said the patient’s sample showed mutations in the hemagglutinin (HA) gene, the part of the virus that plays a key role in it attaching to host cells.
The researchers used the H5N1 strain isolated from the first U.S. human infection with the bovine strain 2.3.4.4b (A/Texas/37/2024) to test how mutations in the HA gene sequence affected the ...
A single mutation in bovine influenza H5N1 hemagglutinin switches specificity to human receptors. Science, 2024; 386 (6726): 1128 DOI: 10.1126/science.adt0180 ...
InDevR’s deep expertise encompasses over 20 influenza seasons across 10+ years. “Through close partnerships with vaccine producers, we understand the unique challenges influenza vaccine development ...